Ned Sharpless to continue where Scott Gottlieb left off at FDA
Sharpless pledged to continue the agency's work promoting innovation and competition while tackling problems like vaccine avoidance and marketing of unsafe and unproven health products.
NCI’s Norman Sharpless named as acting FDA commissioner to succeed Gottlieb
Sharpless, the director of the National Cancer Institute, was reportedly favored by HHS Secretary Alex Azar as outgoing Commissioner Scott Gottlieb's successor.
presented by
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Who has the chops to succeed Scott Gottlieb as FDA commissioner?
Gottlieb, who is expected to step down in about a month, leaves behind a unique legacy and will likely be difficult to replace.